Isoliquiritigenin Attenuates Adipose Tissue Inflammation and Metabolic Syndrome by Modifying Gut Bacteria Composition in Mice.

Riko IshibashiYukihiro FurusawaHiroe HondaYasuharu WatanabeShiho FujisakaMiyu NishikawaShinichi IkushiroShin KuriharaYoshiaki TabuchiKazuyuki TobeKiyoshi TakatsuYoshinori Nagai

Published in: Molecular nutrition & food research (2022)

Alterations in gut bacteria underly the beneficial effects of ILG against adipose tissue inflammation and metabolic disorders. ILG may be a promising prebiotic for the prevention and treatment of metabolic syndrome.

Keyphrases

adipose tissue
metabolic syndrome
insulin resistance
oxidative stress
high fat diet induced
high fat diet
uric acid
cardiovascular risk factors
cardiovascular disease
skeletal muscle
type diabetes
replacement therapy